---
title: "領展宣布從英康保險手中收購新加坡東福坊50.1%的股權，總代價為2.36億新加坡元，這是該基金自2022年以來的首次收購。 — 瑞銀 — DecisionGateway"
description: "statement by 瑞銀, recorded recently — verbatim quote and source citation."
canonical_url: "https://dgw.tmarket.io/claims/01a1e6ae-db2c-71cb-90cd-cc3836c1e4a7"
meta:
  "og:description": "statement by 瑞銀, recorded recently — verbatim quote and source citation."
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "領展宣布從英康保險手中收購新加坡東福坊50.1%的股權，總代價為2.36億新加坡元，這是該基金自2022年以來的首次收購。 — 瑞銀 — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

statement

# **領展宣布從英康保險手中收購新加坡東福坊50.1%的股權，總代價為2.36億新加坡元，這是該基金自2022年以來的首次收購。**

A statement by [**瑞銀**](https://dgw.tmarket.io/actors/01a1d49e-d995-7396-8810-d1e55c335b54). Statements are as reported by the cited publishers — not verified by DecisionGateway.

> *領展(00823.HK)昨晚宣布從英康保險(Income Insurance)手中收購新加坡東福坊(Eastpoint Mall)50.1%的股權，總代價為2.36億新加坡元；這是該基金自2022年以來的首次收購。*

stockintelligencenewsPublished 2026-11-11 [ Read source](https://t.me/stockintelligencenews/5715681)

[**瑞銀 dossier **](https://dgw.tmarket.io/actors/01a1d49e-d995-7396-8810-d1e55c335b54)

## **Discussion**

## **Related claims**

[**領展資產管理宣布向英康保險收購新加坡東福坊50.1%權益，代價為2.395億新加坡元，折合約14.7億港元。**領展資產管理 · statement](https://dgw.tmarket.io/claims/01a1e67b-93cc-7d80-8fdd-e74e8ad51771) [**領展房產基金宣布擬以2.395億新加坡元收購新加坡東福坊50.1%權益。**領展房產基金 · commitment](https://dgw.tmarket.io/claims/01a1e6bf-f2da-7253-b7cf-753ead77a7c1) [**領展房託將以2.395億坡元（約14.7億港元）向英康保險收購新加坡東福坊（Eastpoint Mall）的50.1%權益。**信報 · commitment](https://dgw.tmarket.io/claims/01a1e794-e0dc-7160-a8ba-bfb5ef1b398f) [**領展房產基金 announced it plans to acquire 50.1% of Singapore's Eastpoint Mall for S$239.5 million from 英康保險.**領展房產基金 · commitment](https://dgw.tmarket.io/claims/01a1e6c4-8aca-78de-b6e5-7894fedb5b72) [**英康保險繼續持有東福坊餘下49.9%權益，領展將成為東福坊的資產管理人及物業管理人。**領展資產管理 · statement](https://dgw.tmarket.io/claims/01a1e67b-93fd-7cd3-a659-e1f0bc800049) [**Link REIT will acquire a 50.1% interest in Eastpoint Mall from Income Insurance for SGD 239.5 million.**領展房產基金 · commitment](https://dgw.tmarket.io/claims/01a1e733-4e9c-7741-912f-7774751250c1)

## **More claims by 瑞銀**

[**Although divesting Frontage may affect some global synergies in the short term, the transaction can improve Tigermed's business portfolio and capital allocation while supporting further expansion of overseas clinical CRO business, supplementing working capital and raising shareholder returns.**prediction](https://dgw.tmarket.io/claims/01a1e751-3094-73c5-92e4-9c2e1b97e4fa) [**Tigermed plans to use about 60% of net cash proceeds for overseas clinical CRO expansion and M&A, 20% for daily operations, and the remaining about 20% possibly for dividends or share buybacks.**statement](https://dgw.tmarket.io/claims/01a1e751-3083-714b-9c7b-13200f21418b) [**If the transaction completes, Tigermed can divest non-core businesses including overseas laboratories, CMC and genomics to focus more on clinical CRO services.**prediction](https://dgw.tmarket.io/claims/01a1e751-306d-78f1-ac3c-2b57bdf9bbb3) [**Frontage's laboratory network in the US and Europe is an important platform linking Tigermed to global markets; it supports the strategy of dual IND filings in China and the US and helps Chinese innovative drugmakers expand overseas, so divesting Frontage may affect Tigermed's global footprint and cross-border drug R&D competitiveness to some extent.**statement](https://dgw.tmarket.io/claims/01a1e751-3054-7ca0-a7ed-2ee97b0ffbc4) [**After the privatization, Tigermed plans to acquire Frontage's mainland China non-target businesses at a preliminary valuation of about US$205.5 million; target businesses such as bioanalysis and DMPK will be sold to Charles River Laboratories at a preliminary valuation of about US$470 million; founder Li Song and related trusts may acquire the overseas non-target businesses at a preliminary valuation of about US$84.4 million.**statement](https://dgw.tmarket.io/claims/01a1e751-3034-7cb6-8adc-d678204a44df)

[All claims by 瑞銀](https://dgw.tmarket.io/claims?claimant_id=01a1d49e-d995-7396-8810-d1e55c335b54)

[All claims](https://dgw.tmarket.io/claims)

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts — every claim cited to its public source. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/claims/01a1e6ae-db2c-71cb-90cd-cc3836c1e4a7#webpage","@type":"WebPage","description":"statement by 瑞銀, recorded recently — verbatim quote and source citation.","name":"領展宣布從英康保險手中收購新加坡東福坊50.1%的股權，總代價為2.36億新加坡元，這是該基金自2022年以來的首次收購。 — 瑞銀 — DecisionGateway","url":"https://dgw.tmarket.io/claims/01a1e6ae-db2c-71cb-90cd-cc3836c1e4a7","breadcrumb":{"@id":"https://dgw.tmarket.io/claims/01a1e6ae-db2c-71cb-90cd-cc3836c1e4a7#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/claims/01a1e6ae-db2c-71cb-90cd-cc3836c1e4a7"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/claims/01a1e6ae-db2c-71cb-90cd-cc3836c1e4a7#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Claims","item":"https://dgw.tmarket.io/claims","position":2},{"@type":"ListItem","name":"領展宣布從英康保險手中收購新加坡東福坊50.1%的股權，總代價為2.36億新加坡元，這是該基金自2022年以來的首次收購…","position":3}]},{"@id":"https://dgw.tmarket.io/claims/01a1e6ae-db2c-71cb-90cd-cc3836c1e4a7#/schema/quotation/1","@type":"Quotation","dateCreated":"2026-11-11","isBasedOn":"https://t.me/stockintelligencenews/5715681","text":"領展(00823.HK)昨晚宣布從英康保險(Income Insurance)手中收購新加坡東福坊(Eastpoint Mall)50.1%的股權，總代價為2.36億新加坡元；這是該基金自2022年以來的首次收購。","url":"/claims/01a1e6ae-db2c-71cb-90cd-cc3836c1e4a7","spokenByCharacter":{"@type":"Person","name":"瑞銀","@id":"/actors/01a1d49e-d995-7396-8810-d1e55c335b54"}}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.
